Jennifer Hayes LoPresto, Senior Vice President at HealthStream Inc (NASDAQ:HSTM), filed a Form 4 on September 22, 2026, reporting the acquisition of three tranches of restricted share units on September 18, 2026, along with a disposition of common stock.

Key Highlights

  • Three RSU grants awarded: LoPresto received 1,540, 9,237, and 3,079 restricted share units on September 18, 2026, for a combined total of 13,856 RSUs.
  • No purchase price: All three RSU grants were acquired at $0 per unit, according to the filing.
  • Multi-year vesting schedules: The grants are subject to four-year vesting schedules, each contingent upon continued service at the time of vesting.
  • Performance-based tranche: The 3,079-unit grant includes vesting contingent on performance criteria set annually by the Compensation Committee of the Board of Directors, with up to 25% eligible to vest per period.
  • Common stock disposition: The filing also reports a disposition of 6,585 shares of common stock, with no transaction date, price, or transaction code recorded in the table.
  • Reporting person role: LoPresto is identified as a Senior Vice President of HealthStream Inc.

HealthStream SVP LoPresto RSU Grant Details and Vesting Terms

According to the filing, Jennifer Hayes LoPresto received three separate restricted share unit grants from HealthStream Inc on September 18, 2026. The filing states that each RSU "represents the contingent right to receive one share of common stock upon vesting of the unit." All three grants were recorded at a price of $0 and are directly owned.

The 1,540-unit grant carries a four-year vesting schedule with the following structure: 15% vest on September 18, 2027; 20% on September 18, 2028; 30% on September 18, 2029; and the remaining 35% on September 18, 2030, each contingent upon continued service. The 9,237-unit grant vests in four equal annual installments beginning September 18, 2027. The 3,079-unit grant is subject to both continued service and the achievement of performance criteria established annually by the Compensation Committee. Under that grant, up to 25% may vest on February 23, 2028, up to 25% on February 23, 2029, up to 25% on February 23, 2030, and up to 25% on February 23, 2031, based on annual performance periods. The filing notes that "RSUs that do not vest during a performance period may become eligible for vesting during the next performance period."

The filing also discloses a disposition of 6,585 shares of common stock in Table I, though the transaction date, transaction code, and price fields are not populated in the reported table. Following all reported transactions, LoPresto directly holds 1,540, 9,237, and 3,079 RSUs in the respective derivative security positions.

What Was Disclosed

The Form 4 discloses three RSU grants totaling 13,856 units to HealthStream SVP Jennifer Hayes LoPresto on September 18, 2026, each with distinct four-year vesting schedules, one of which is partially performance-based, and a separate disposition of 6,585 common shares.